| Men | Women | p Value | |
| Number of patients | 14 657 | 5633 | |
| Aspirin (%) | 94.3 | 92.2 | <0.001 |
| Clopidogrel (%) | 44.7 | 36.1 | <0.001 |
| GPIIb/IIIa antagonist (%) | 36.9 | 27.1 | <0.001 |
| Unfractionated heparin (%) | 73.0 | 69.4 | <0.001 |
| LMWH (%) | 32.2 | 34.6 | 0.006 |
| β Blocker (%) | 73.6 | 67.3 | <0.001 |
| ACE inhibitor (%) | 39.4 | 39.4 | 1.000 |
| Angiotensin antagonist (%) | 4.5 | 6.0 | <0.001 |
| Calcium channel blocker (%) | 6.5 | 7.5 | 0.013 |
| Nitrate (%) | 67.1 | 67.4 | 0.657 |
| Lipid-lowering drug (%) | 73.1 | 63.6 | <0.001 |
| Thrombolysis (%) | 18.7 | 15.2 | <0.001 |
| PCI (%) | 36.6 | 27.2 | <0.001 |
LMWH, low molecular weight heparin; PCI, percutaneous coronary intervention.